Lucius Partners Portfolio Company Voltron Therapeutics, Inc. Announces Completion of a Trial Protocol to Study its Self Assembling Vaccine to Target Prostate Stem Cell Antigen

2025-07-24T17:06:09-04:00

Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces [...]